Susanna Gatti High's Net Worth
$8.13 Million
Who is Susanna Gatti High?
Susanna Gatti High has an estimated net worth of $8.13 Million. This is based on reported shares across multiple companies, which include Dyne Therapeutics, Inc., and bluebird bio, Inc..
SEC CIK
Susanna Gatti High's CIK is 0001691005
Past Insider Trading and Trends
2018 was Susanna Gatti High's most active year for acquiring shares with 7 total transactions. Susanna Gatti High's most active month to acquire stocks was the month of November. 2018 was Susanna Gatti High's most active year for disposing of shares, totalling 25 transactions. Susanna Gatti High's most active month to dispose stocks was the month of December. 2018 saw Susanna Gatti High paying a total of $1,328,583.45 for 65,397 shares, this is the most they've acquired in one year. In 2018 Susanna Gatti High cashed out on 32,005 shares for a total of $4,901,807.38, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dyne Therapeutics, Inc. (DYN) Snapshot price: $21.5
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.83% | -29.49K |
$26.59 | -$784,247.99 | 156.8K |
Mar 8 - Mar 11
| |||
Form 4
| -0.85% | -1.59K |
$25.85 | -$41,127.35 | 186.29K |
Mar 7
| |||
Form 4
| -0.85% | -1.62K |
$10.72 | -$17,323.52 | 187.88K |
Dec 11
| |||
Form 4
| +100.30% | 94.89K |
—
|
—
| 189.5K |
Nov 15
| |||
Form 4
| -9.51% | -9.94K |
$7.40 | -$73,548.60 | 94.61K |
Nov 2
| |||
Form 4
| -2.49% | -2.67K |
$9.41 | -$25,143.52 | 104.54K |
Sep 18
| |||
Form 4
| -1.50% | -1.64K |
$10.41 | -$17,020.35 | 107.22K |
Sep 12
| |||
Form 4
| -1.47% | -1.63K |
$12.43 | -$20,198.75 | 108.85K |
Jun 13
| |||
Form 4
| -1.39% | -1.56K |
$13.33 | -$20,781.47 | 110.48K |
Scheduled
|
Mar 14
| ||
Form 4
| +62.87% | 43.25K |
$10.87 | -$8,163.37 | 112.03K |
Scheduled
|
Dec 9 - Dec 12
| ||
Form 4
| -3.68% | -2.63K |
$13.70 | -$36,017.30 | 68.79K |
Scheduled
|
Sep 20
| ||
Form 4
| -1.09% | -786.00 |
$14.05 | -$11,043.30 | 71.42K |
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 5
| |||
Form 4
| -1.10% | -802.00 |
$4.95 | -$3,969.90 | 72.2K |
Scheduled
|
Jun 14
| ||
Form 4
| -1.04% | -765.00 |
$8.73 | -$6,678.45 | 73K |
Scheduled
|
Mar 11
| ||
Form 4
| +120.51% | 40.31K |
—
|
—
| 73.77K |
Dec 10
| |||
Form 4
| -6.83% | -2.45K |
$17.22 | -$42,206.22 | 33.45K |
Scheduled
|
Sep 23
| ||
Form 4
|
∞
| 35.9K |
—
|
—
| 35.9K |
Sep 16 - Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
bluebird bio, Inc. (BLUE) Snapshot price: $0.95
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -11.92% | -1.86K |
$87.18 | -$197,168.36 | 13.75K |
Scheduled
|
Dec 6
| ||
Form 4
| -12.01% | -1.88K |
$105.71 | -$198,198.11 | 13.73K |
Scheduled
|
Dec 6
| ||
Form 4
| -10.80% | -1.89K |
$113.83 | -$215,135.30 | 15.61K |
Dec 3
| |||
Form 4
|
—
|
0
|
$133.88 | -$456,616.65 | 17.5K |
Scheduled
|
Jun 4
| ||
Form 4
|
—
|
0
|
$135.66 | -$139,921.49 | 17.5K |
Scheduled
|
Feb 28
| ||
Form 4
| +55.56% | 6.25K |
—
|
—
| 17.5K |
Feb 1
| |||
Form 4
| -17.99% | -2.47K |
$132.28 | -$2,366,184.03 | 11.25K |
Scheduled
|
Jan 30
| ||
Form 4
| -8.55% | -1.28K |
$172.15 | -$220,696.30 | 13.72K |
Dec 1
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||